By Matt Grossman
Boston Scientific Corp. on Wednesday posted a smaller fourth-quarter profit to finish 2020, as sales from its cardiovascular and medical-devices segments declined year over year.
The Marlborough, Mass.-based medical-products company logged a profit of 10 cents a share, compared with $2.83 a share a year earlier. Net income available to common stockholders was $138 million, down from $4 billion in the prior-year period, it said.
Boston Scientific's adjusted profit was 23 cents a share, the company said.
The company posted revenue of $2.71 billion, down from $2.91 billion.
Medical-surgical sales climbed 1.5% year over year to $892 million, but the company's other divisions lost ground. Cardiovascular sales declined 12% year over year and rhythm-and-neuro sales sank by 6.1%. The medical-devices segment was also down 6.1%, it said.
Write to Matt Grossman at firstname.lastname@example.org
(END) Dow Jones Newswires
February 03, 2021 07:11 ET (12:11 GMT)Copyright (c) 2021 Dow Jones & Company, Inc.